|
Market Closed -
Hong Kong S.E.
09:08:07 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.4450 HKD | 0.00% |
|
+3.49% | -11.00% |
| 08-28 | Mabpharm Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-24 | Mabpharm Limited Receives Approval for New Drug Application of CMAB807X (Denosumab Injection) | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | +3.49% | +11.25% | +11.25% | -11.00% | -46.39% | -10.10% | -54.12% | - | 234M | |
| +1.03% | -3.11% | +21.46% | +56.01% | +72.10% | +39.80% | +94.60% | +17.48% | - | 68.21B | |
| +1.62% | +0.33% | +24.70% | +29.77% | +25.64% | +48.61% | +89.64% | +207.37% | +6,233.33% | 64.25B | |
| +2.28% | -0.71% | +25.45% | +19.06% | -29.04% | -15.00% | +368.35% | +322.38% | +827.21% | 26.54B | |
| +1.50% | -8.37% | +11.80% | +15.71% | +8.34% | +2.50% | -15.46% | -68.61% | - | 25.61B | |
| +1.30% | +0.74% | +17.82% | +40.82% | +7.30% | +31.66% | -18.33% | -28.97% | +107.34% | 19.88B | |
| -0.38% | -12.42% | +23.11% | +50.48% | +208.00% | +224.86% | +373.18% | +1,794.40% | +850.57% | 17.13B | |
| +0.65% | -5.83% | +1.90% | +13.23% | +25.70% | +1.44% | +544.44% | - | - | 14.93B | |
| +1.94% | +2.99% | +4.94% | +19.04% | +31.83% | +55.41% | +159.45% | +185.05% | +400.69% | 14.1B | |
| +0.70% | +0.89% | +12.80% | +20.06% | -6.64% | +24.67% | +194.68% | +547.71% | +4,480.33% | 12.45B | |
| +0.76% | -6.67% | -3.29% | +17.45% | +25.29% | +223.91% | +196.75% | +20.38% | +1,063.36% | 11.69B | |
| +0.53% | +0.07% | +9.16% | -4.17% | -18.58% | -40.27% | +807.01% | +90.37% | +114.14% | 11.3B | |
| -0.67% | -10.28% | -7.05% | +0.21% | +11.84% | +43.21% | +102.10% | +111.99% | +585.91% | 9.93B | |
| +0.56% | -0.23% | +13.86% | +28.56% | +32.10% | +93.12% | +19.51% | +128.96% | - | 9.05B | |
| -0.57% | -5.09% | +9.51% | +8.30% | +295.45% | +228.99% | +436.30% | -32.38% | - | 8.34B | |
| -2.89% | -8.06% | -9.34% | +24.44% | +162.70% | +417.50% | +477.68% | -53.79% | -44.92% | 7.8B | |
| +1.44% | -3.46% | -1.03% | +23.37% | +5.67% | -5.92% | +258.15% | +280.70% | - | 7.26B | |
| -3.58% | -0.55% | -2.93% | -24.56% | -51.01% | - | - | - | - | 6.83B | |
| -0.01% | -3.88% | -5.80% | -5.79% | +1.80% | +13.74% | +53.76% | +13.05% | +164.34% | 6.84B | |
| +0.12% | -7.00% | +21.79% | +24.98% | +26.77% | +68.60% | +824.50% | +43.88% | - | 6.81B | |
| Average | +0.30% | -3.94% | +9.01% | +18.41% | +41.21% | +74.23% | +260.85% | +195.88% | +1,343.84% | 17.46B | |
| Weighted average by Cap. | +0.89% | -3.38% | +15.03% | +28.20% | +41.75% | +59.02% | +199.34% | +202.09% | +2,579.83% |
- Stock Market
- Stocks
- 2181 Stock
- Sector Mabpharm Limited
Select your edition
All financial news and data tailored to specific country editions
